The pause is a setback for Johnson & Johnson’s effort to prove its vaccine is safe and can prevent people from getting the coronavirus.
Johnson & Johnson just paused its coronavirus vaccine trials after an ‘unexplained illness’ in a participant
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over